199 related articles for article (PubMed ID: 28434080)
1. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.
Ariake K; Motoi F; Ohtsuka H; Fukase K; Masuda K; Mizuma M; Hayashi H; Nakagawa K; Morikawa T; Maeda S; Takadate T; Naitoh T; Egawa S; Unno M
Surg Today; 2017 Dec; 47(12):1434-1442. PubMed ID: 28434080
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.
Ozaki H; Hiraoka T; Mizumoto R; Matsuno S; Matsumoto Y; Nakayama T; Tsunoda T; Suzuki T; Monden M; Saitoh Y; Yamauchi H; Ogata Y
Surg Today; 1999; 29(1):16-22. PubMed ID: 9934826
[TBL] [Abstract][Full Text] [Related]
3. Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.
Perinel J; Nappo G; El Bechwaty M; Walter T; Hervieu V; Valette PJ; Feugier P; Adham M
Langenbecks Arch Surg; 2016 Dec; 401(8):1131-1142. PubMed ID: 27476146
[TBL] [Abstract][Full Text] [Related]
4. Survival benefits of portal vein resection for pancreatic cancer.
Nakagohri T; Kinoshita T; Konishi M; Inoue K; Takahashi S
Am J Surg; 2003 Aug; 186(2):149-53. PubMed ID: 12885608
[TBL] [Abstract][Full Text] [Related]
5. Portal vein resection in pancreatic head carcinoma. Part 2: Clinical significance.
Tuech JJ; Pessaux P; Arnaud JP
Hepatogastroenterology; 2001; 48(39):888-91. PubMed ID: 11462949
[TBL] [Abstract][Full Text] [Related]
6. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
[TBL] [Abstract][Full Text] [Related]
7. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
8. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
10. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P
Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385
[TBL] [Abstract][Full Text] [Related]
14. Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival.
Klein F; Berresheim F; Felsenstein M; Malinka T; Pelzer U; Denecke T; Pratschke J; Bahra M
Eur J Surg Oncol; 2018 Jul; 44(7):1094-1099. PubMed ID: 29778616
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
[TBL] [Abstract][Full Text] [Related]
16. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?
Sasson AR; Hoffman JP; Ross EA; Kagan SA; Pingpank JF; Eisenberg BL
J Gastrointest Surg; 2002; 6(2):147-57; discussion 157-8. PubMed ID: 11992799
[TBL] [Abstract][Full Text] [Related]
17. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy.
Hwang HK; Jung MJ; Lee SH; Kang CM; Lee WJ
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):497-507. PubMed ID: 27295957
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
20. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Kozuki A; Saisaka Y; Tokumaru T; Iiyama T; Noda Y; Hata Y; Matsumoto M
Langenbecks Arch Surg; 2015 May; 400(4):487-94. PubMed ID: 25940756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
